Involvement of previous non-participants cannot fully compensate for lower participation in a second round of FIT-screening

被引:16
作者
Denters, M. J. [1 ]
Deutekom, M. [2 ]
Bossuyt, P. M. [3 ]
van Rijn, A. F. [1 ]
Fockens, P. [1 ]
Dekker, E. [1 ]
机构
[1] Univ Amsterdam, Dept Gastroenterol & Hepatol, Acad Med Ctr, NL-1105 AZ Amsterdam, Netherlands
[2] Univ Amsterdam, Dept Social Med, Acad Med Ctr, NL-1105 AZ Amsterdam, Netherlands
[3] Univ Amsterdam, Dept Biostat & Epidemiol, Acad Med Ctr, NL-1105 AZ Amsterdam, Netherlands
关键词
Participation; Fecal immunochemical test (FIT); Colorectal neoplasia; Mass screening; FECAL-OCCULT-BLOOD; COLORECTAL-CANCER; RANDOMIZED-TRIAL; COLON-CANCER; FOLLOW-UP; POPULATION; PROGRAM; PILOT; PREDICTORS; IMPLEMENTATION;
D O I
10.1016/j.canep.2013.01.007
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Introduction: The effectiveness of colorectal cancer (CRC) screening programs depends on repeated participation. Little is known on later rounds in programs that use the fecal immunochemical test (FIT), in particular whether previous participants are likely to participate again, and if non-participants persist in declining. We compared overall participation in a second round to that in a first round, and evaluated differences in participation rates based on previous response. Methods: Asymptomatic persons aged 50-74 years were invited to a second round of a FIT-based CRC screening pilot. We assessed the participation rate overall and within second round subgroups of previous participants, previous non-participants, and first time invitees. We also assessed whether participation rates were similar for males and females and for age groups. Results: In the first screening round, 2871 of 5309 invitees returned the FIT (participation rate of 57%). This was higher than in the second in which 3187 of 5925 participated (54%; p = 0.0008). Second round participation rate was 85% (2034/2385) among previous participants, 18% (325/1826) among previous non-participants and 48% (828/1714) among first time invitees (p<.0001). Overall, males and persons aged under 55 were less likely to participate. Conclusions: Participation in a second round of FIT-screening was significantly lower than in the first round, largely due to a drop in participation in first round participants, and a relatively low response among first time invitees. This loss of uptake was partially compensated by a willingness to be screened in previous non-participants. (C) 2013 Elsevier Ltd. All rights reserved.
引用
收藏
页码:330 / 335
页数:6
相关论文
共 27 条
[1]   Reattendance in the Swiss mammography screening pilot programme [J].
Bulliard, JL ;
De Landtsheer, JP ;
Levi, F .
JOURNAL OF MEDICAL SCREENING, 2004, 11 (02) :59-64
[2]   A randomised trial of the impact of new faecal haemoglobin test technologies on population participation in screening for colorectal cancer [J].
Cole, SR ;
Young, GP ;
Esterman, A ;
Cadd, B ;
Morcom, J .
JOURNAL OF MEDICAL SCREENING, 2003, 10 (03) :117-122
[3]   Breast, cervical, and colateral carcinoma screening in a demographically defined region of the southern US [J].
Coughlin, SS ;
Thompson, TD ;
Seeff, L ;
Richards, T ;
Stallings, F .
CANCER, 2002, 95 (10) :2211-2222
[4]   Short term outcomes of the first round of a pilot colorectal cancer screening programme with guaiac based faecal occult blood test [J].
Denis, Bernard ;
Ruetsch, Marcel ;
Strentz, Patrick ;
Vogel, Jean Yves ;
Guth, Francis ;
Boyaval, Jean Marc ;
Pagnon, Xavier ;
Ebelin, Jean Francois ;
Gendre, Isabelle ;
Perrin, Philippe .
GUT, 2007, 56 (11) :1579-1584
[5]   Implementation of population screening for colorectal cancer by repeated fecal occult blood test in the Netherlands [J].
Denters, Maaike J. ;
Deutekom, Marije ;
Fockens, Paul ;
Bossuyt, Patrick M. M. ;
Dekker, Evelien .
BMC GASTROENTEROLOGY, 2009, 9
[6]   Uptake of faecal occult blood test colorectal cancer screening by different ethnic groups in the Netherlands [J].
Deutekom, M. ;
van Rijn, A. F. ;
Dekker, E. ;
Blaauwgeers, H. ;
Stronks, K. ;
Fockens, P. ;
Essink-Bot, M. -L. .
EUROPEAN JOURNAL OF PUBLIC HEALTH, 2009, 19 (04) :400-402
[7]   Reduction in colorectal cancer mortality by fecal occult blood screening in a French controlled study [J].
Faivre, J ;
Dancourt, V ;
Lejeune, C ;
Tazi, MA ;
Lamour, J ;
Gerard, D ;
Dassonville, F ;
Bonithon-Kopp, C .
GASTROENTEROLOGY, 2004, 126 (07) :1674-1680
[8]   Comparison of CT colonography, colonoscopy, sigmoidoscopy and faecal occult blood tests for the detection of advanced adenoma in an average risk population [J].
Graser, A. ;
Stieber, P. ;
Nagel, D. ;
Schaefer, C. ;
Horst, D. ;
Becker, C. R. ;
Nikolaou, K. ;
Lottes, A. ;
Geisbuesch, S. ;
Kramer, H. ;
Wagner, A. C. ;
Diepolder, H. ;
Schirra, J. ;
Roth, H. J. ;
Seidel, D. ;
Goeke, B. ;
Reiser, M. F. ;
Kolligs, F. T. .
GUT, 2009, 58 (02) :241-248
[9]   Predictors of fecal occult blood test (FOBT) completion among low-income adults [J].
Greiner, KA ;
James, AS ;
Born, W ;
Hall, S ;
Engelman, KK ;
Okuyemi, KS ;
Ahluwalia, JS .
PREVENTIVE MEDICINE, 2005, 41 (02) :676-684
[10]   Randomised controlled trial of faecal-occult-blood screening for colorectal cancer [J].
Hardcastle, JD ;
Chamberlain, JO ;
Robinson, MHE ;
Moss, SM ;
Amar, SS ;
Balfour, TW ;
James, PD ;
Mangham, CM .
LANCET, 1996, 348 (9040) :1472-1477